Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials



Rating:

Share or cite this content

Citations should be made in the following way:
J. Mullol (Barcelona, Catalonia, Spain), G. Canonica (Milan, Italy), M. Wagenmann (Düsseldorf, Germany), A. Coste (Creteil, France), P. Hellings (Leuven, Belgium), S. Nash (Tarrytown, NY, United States of America), S. Kamat (Tarrytown, NY, United States of America), U. Mujumdar (Cambridge, MA, United States of America), J. Msihid (Chilly-Mazarin, France), A. Khan (Chilly-Mazarin, France), S. Siddiqui (Tarrytown, NY, United States of America), J. Jacob-Nara (Cambridge, MA, United States of America), Y. Deniz (Tarrytown, NY, United States of America), P. Rowe (Bridgewater, NJ, United States of America). SNOT-22 items and association with objective measures in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from SINUS-24 and SINUS-52 trials. 2520

Member's Comments

No comment yet.

Related content which might interest you: Dupilumab improves all ACQ-5 individual items in patients with chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma: results from a phase 2a trial Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Dupilumab improves patient-reported outcomes in chronic sinusitis with nasal polyps patients with comorbid asthma: Results from a phase 2a trial Source: International Congress 2016 – Best abstracts in asthma and COPD Year: 2016 Dupilumab reduces blood and nasal biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps with and without comorbid asthma: SINUS-52 trial Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Tezepelumab efficacy in patients with severe, uncontrolled asthma and comorbid nasal polyps in NAVIGATOR Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 The relationship between asthma symptom control scores and rhinosinusitis scores in difficult-to-treat asthma Source: Annual Congress 2008 - Understanding airway inflammation Year: 2008 Dupilumab improves mental health measures in patients with chronic rhinosinusitis and nasal polyposis (CRSwNP) Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 Mepolizumab reduces nasal symptoms in asthmatic patients with chronic rhino-sinusitis and nasal polyposis: a 12 months real-life study Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Quality of life, clinical symptoms and nasal obstruction in patients with allergic rhinitis Source: Eur Respir J 2003; 22: Suppl. 45, 418s Year: 2003 Real-world evidence of reported symptoms and quality of life burden associated with chronic rhinosinusitis with nasal polyposis and comorbid asthma status Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases Year: 2021 Effect of mepolizumab on chronic rhinosinusitis symptoms and nasal hypersensitivity in patients with or without nasal polyps Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020 Performance of COPD diagnostic questionnaires in patients with moderate and severe obstruction Source: Eur Respir J 2004; 24: Suppl. 48, 473s Year: 2004 Impact of chronic rhinosinusitis on clinical presentation in patients with asthma Source: Eur Respir J 2006; 28: Suppl. 50, 238s Year: 2006 Improvement in rhinosinusitis health related quality of life in patients with severe eosinophilic asthma Source: International Congress 2017 – Management of asthma in different situations Year: 2017 Effect of dupilumab on patient-reported sleep outcomes in patients with severe asthma Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Evaluating symptom outcomes in patients with COPD: reliability and validity of the breathlessness, cough and sputum scale Source: Eur Respir J 2001; 18: Suppl. 33, 461s Year: 2001 Relationship between objective measures of airflow obstruction and asthma symptoms in adults Source: Eur Respir J 2001; 18: Suppl. 33, 379s Year: 2001 Dupilumab improves patient-reported outcomes in uncontrolled persistent asthma patients with ongoing allergic rhinitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Are asthma symptom intensity scales better than biomarkers for diagnosing asthma? A prospective observational study Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 The impact of targeted therapy in children with uncontrolled allergic persistent severe asthma and nasal polyps Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities Year: 2017 Symptom variability in patients with severe COPD: a pan-European cross-sectional study Source: Eur Respir J 2011; 37: 264 Year: 2011